De novo membranous nephropathy (MN) in kidney allografts. A peculiar form of alloimmune disease?

Transplant International

Volumn 25, Issue 12, 2012, Pages 1205-1210

  Ponticelli, Claudio ^a   Glassock, Richard J ^b  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

chronic rejection; glomerulonephritis pathogenesis; kidney allograft; membranous nephropathy; proteinuria; transplant glomerulonephritis

Indexed keywords

ANTIBODY; CYCLOSPORIN; CYTOKINE; DONOR SPECIFIC ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G4; INFLAMMASOME; PENTRAXIN; PHOSPHOLIPASE A2 RECEPTOR 1 ANTIBODY; RAPAMYCIN; UBIQUITIN C TERMINAL HYDROLASE L1; UBIQUITIN THIOLESTERASE; UNCLASSIFIED DRUG;

ANTIBODY MEDIATED REJECTION; ANTIGEN PRESENTATION; CD4 LYMPHOCYTE COUNT; CHRONIC GRAFT REJECTION; CLINICAL FEATURE; CYTOKINE RELEASE; DENDRITIC CELL; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTRON MICROSCOPY; GLOMERULUS CAPILLARY; GRAFT SURVIVAL; HEPATITIS B; HUMAN; IMMUNE COMPLEX DEPOSITION; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY CELL; INNATE IMMUNITY; INTRACELLULAR SIGNALING; KIDNEY ALLOGRAFT REJECTION; MACROPHAGE; MEDIATOR RELEASE; MEMBRANOUS GLOMERULONEPHRITIS; MONOCYTE; NATURAL KILLER CELL; NEPHROTIC SYNDROME; PATHOGENESIS; PODOCYTE; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; RENAL GRAFT DYSFUNCTION; REVIEW;

EID: 84869085982     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2012.01548.x     Document Type: Review

References (52)

1. Cosyns JP, Couchoud C, Pouteil-Noble C, Squifflet JP, Pirson Y,. Recurrence of membranous nephropathy after renal transplantation: probability, outcome and risk factors. Clin Nephrol 1998; 50: 144.
2. Moroni G, Gallelli B, Quaglini S, et al. Long-term outcome of renal transplantation in patients with idiopathic membranous glomerulonephritis (MN). Nephrol Dial Transplant 2010; 25: 3408.
3. El-Zoghby ZM, Grande JP, Fraile MG, Norby SM, Fervenza FC, Cosio FG,. Recurrent idiopathic membranous nephropathy: early diagnosis by protocol biopsies and treatment with anti-CD20 monoclonal antibodies. Am J Transplant 2009; 9: 2800.
4. Ponticelli C, Glassock RJ,. Posttransplant recurrence of primary glomerulonephritis. Clin J Am Soc Nephrol 2010; 5: 2363.
5. Charpentier B, Lévy M,. Cooperative study of de novo extramembranous glomerulonephritis in renal allografts in humans: report of 19 new cases in 1550 renal transplant patients of the transplantation group of the Ile de France. Nephrologie 1982; 3: 158.
6. Aline-Fardin A, Rifle G, Martin L, et al. Recurrent and de novo membranous glomerulopathy after kidney transplantation. Transplant Proc 2009; 41: 669.
7. Schwarz A, Krause PH, Offermann G, Keller F,. Recurrent and de novo renal disease after kidney transplantation with or without cyclosporine A. Am J Kidney Dis 1991; 17: 524.
8. Davison AM, Johnston PA,. Allograft membranous nephropathy. Nephrol Dial Transplant 1992; 7 (Suppl. 1): 114.
9. Antignac C, Hinglais N, Gubler MC, et al. De novo membranous glomerulonephritis in renal allografts in children. Clin Nephrol 1988; 30: 1-6.
10. Steinmuller DR, Stilmant MM, Idelson BA, et al. De novo development of membranous nephropathy in cadaver renal allografts. Clin Nephrol 1978; 9: 210.
11. Briner J, Binswanger U, Largiadèr F,. Recurrent and de novo membranous glomerulonephritis in renal cadaver allotransplants. Clin Nephrol 1980; 13: 189.
12. Monga G, Mazzucco G, Basolo B, et al. Membranous glomerulonephritis (MGN) in transplanted kidneys: morphologic investigation on 256 renal allografts. Mod Pathol 1993; 6: 249.
13. Sebire NJ, Bockenhauer D,. Posttransplant de novo membranous nephropathy in childhood. Fetal Ped Pathol 2005; 24: 95.
14. Dische FE, Herbertson BM, Melcher DH, Morley AR,. Membranous glomerulonephritis in transplant kidneys: recurrent or de novo disease in four patients. Clin Nephrol 1981; 15: 154.
15. Truong L, Gelfand J, D'Agati V, et al. De novo membranous glomerulonephropathy in renal allografts: a report of ten cases and review of the literature. Am J Kidney Dis 1989; 14: 131.
16. Honda K, Horita S, Toki D, et al. De novo membranous nephropathy and antibody-mediated rejection in transplanted kidney. Clin Transplant 2011; 25: 191.
17. Lim BJ, Kim MS, Kim YS, Kim SI, Jeong HJ,. C4d deposition and multilayering of peritubular capillary basement membrane in posttransplantation membranous nephropathy indicate its association with antibody-mediated injury. Transplant Proc 2012; 44: 619.
18. Kearney N, Podolak J, Matsumura L, Houghton D, Troxell M,. Patterns of IgG subclass deposits in membranous glomerulonephritis in renal allografts. Transplant Proc 2011; 43: 3743.
19. Cosyns JP, Pirson Y, Squifllet JP, et al. De novo membranous nephropathy in human renal allografts: report of nine patients. Kidney Int 1982; 22: 177.
20. Heidet L, Gagnadoux MF, Beziau A, et al. Recurrence of de novo membranous glomerulonephritis on renal grafts. Clin Nephrol 1994; 41: 314.
21. Teixeira Costa F, Pinto JR, Carvalho F, Galvão MJ,. An early case of de novo membranous nephropathy in a renal transplant patient. Transplant Proc 2002; 34: 364.
22. Gough J, Yilmaz A, Yilmaz S, Benediktsson H,. Recurrent and de novo glomerular immune-complex deposits in renal transplant biopsies. Arch Pathol Lab Med 2005; 129: 231.
23. Poduval RD, Josephson MA, Javaid B,. Treatment of de novo and recurrent membranous nephropathy in renal transplant patients. Semin Nephrol 2003; 23: 392.
24. Lai KN, Li PKT, Lui SF, et al. Membranous nephropathy related to hepatitis B virus. N Engl J Med 1991; 324: 1457.
25. Morales JM, Pascual-Capdevila J, Campistol JM, et al. Membranous glomerulonephritis associated with hepatitis C virus infection in renal transplant patients. Transplantation 1997; 63: 1634.
26. Cruzado JM, Carrera M, Torras J, Grinyà JM,. Hepatitis C virus infection and de novo glomerular lesions in renal allografts. Am J Transplant 2001; 1: 171-178.
27. Ozdemir BH, Ozdemir FN, Sezer S, Colak T, Haberal M,. De novo glomerulonephritis in renal allografts with hepatitis C virus infection. Transplant Proc 2006; 38: 492-5.
28. Prasad GV, Sweet JM, Cole EH, Cardella CJ,. Allograft de novo membranous nephropathy complicating Alport's syndrome. Nephron 2000; 86: 227.
29. Hoitsma AJ, Kroon AA, Wetzels JF, Assmann KJ, Berden JH, Koene RA,. Association between ureteral obstruction and de novo membranous nephropathy in renal allografts. Transplant Proc 1990; 22: 1388.
30. Robles NR, Gomez-Campdera FJ, Anaya F, Niembro E, Rengel MA, Valderrabano F,. Is the development of 'de novo' allograft membranes nephropathy linked to ureteric obstruction? Nephrol Dial Transplant 1993; 8: 883.
31. Koselj-Kajtna M, Rott T, Koselj M, et al. Recurrent immunoglobulin A nephropathy complicated with de novo membranous glomerulonephritis in renal allografts. Transplant Proc 2002; 34: 3117.
32. Dittrich F, Schumaldienst S, Soleiman A, Horl W, Pohanha E,. Rapamycin-associated posttransplantation glomerulonephritis and its remission after reintroduction of calcineurin inhibitor therapy. Transplant Int 2004; 17: 215.
33. Ward HJ, Kovie MA,. Immunopathologic features of de novo membranous nephropathy in renal allografts. Transplantation 1988; 45: 524.
34. Glassock RJ,. The pathogenesis of membranous nephropathy: evolution and revolution. Curr Opin Nephrol Hypertens 2012; 21: 235.
35. Bansal VK, Koseny GA, Fresco R, et al. De novo membranous nephropathy following transplantation between conjoint twins. Transplantation 1986; 41: 404.
36. El Kossi M, Harmer A, Goodwin J, et al. De novo membranous nephropathy associated with donor-specific alloantibody. Clin Transplant 2008; 22: 124.
37. 2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009; 361: 11.
38. Debiec H, Martin L, Jouanneau C, et al. Autoantibodies specific for the phospholipase A2 receptor in recurrent and De Novo membranous nephropathy. Am J Transplant 2011; 11: 2144.
39. Stanescu HC, Argos-Burgos M, Mediar A, et al. Risk HLA-DQA1 and PLRA(2)R1 alleles in idiopathic membranous nephropathy. N Engl J Med 2011; 364: 616.
40. Prunotto M, Carnevali ML, Candiano G, et al. Autoimmunity in membranous nephropathy targets aldose reductase and SOD2. J Am Soc Nephrol 2010; 21: 507.
41. Bruschi M, Carnevali ML, Murtas C, et al. Direct characterization of target podocyte antigens and auto-antibodies in human membranous glomerulonephritis: alfa-enolase and borderline antigens. J Proteomics 2011; 74: 2008.
42. Cornell LD,. IgG4-related kidney disease. Curr Opin Nephrol Hypertens 2012; 21: 279.
43. Glassock RJ,. Secondary membranous glomerulonephritis. Nephrol Dial Transplant 1992; 7 (Suppl. 1): 64.
44. Meyer-Schwesinger C, Dehde S, Klug P, et al. Nephrotic syndrome and subepithelial deposits in a mouse model of immune-mediated anti-podocyte glomerulonephritis. J Immunol 2011; 187: 3218.
45. Liu Y, Wu J, Wu H, et al. UCH-L1 expression of podocytes in diseased glomeruli and in vitro. J Pathol 2009; 217: 642.
46. Sistani L, Dunér F, Udumala S, et al. Pdlim2 is a novel actin-regulating protein of podocyte foot processes. Kidney Int 2011; 80: 1045.
47. Debiec H, Guigonis V, Mougenot B, et al. Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N Engl J Med 2002; 346: 2053.
48. Debiec H, Nauta J, Coulet F, et al. Role of truncating mutations in MME gene in fetomaternal alloimmunisation and antenatal glomerulopathies. Lancet 2004; 364: 1252.
49. Ronco P, Debiec H, Guigonis V,. Mechanisms of disease: alloimmunization in renal diseases. Nat Clin Pract Nephrol 2006; 2: 388.
50. Stevenson WS, Nankivell BJ, Hertzberg MS,. Nephrotic syndrome after stem cell transplantation. Clin Transplant 2005; 19: 141.
51. Medzhitov R,. Toll-like receptors and innate immunity. Nat Rev Immunol 2001; 1: 135.
52. Couser WG,. Basic and translational concepts of immune-mediated glomerular diseases. J Am Soc Nephrol 2012; 23: 381.